Literature DB >> 20198459

Differential diagnosis of angioimmunoblastic T-cell lymphoma with seropositivity for anti-HTLV antibody from adult T-cell leukemia/lymphoma.

Shih-Sung Chuang1, Ryo Ichinohasama, Jan-Show Chu, Koichi Ohshima.   

Abstract

Angioimmunoblastic lymphoma (AITL) is a nodal peripheral T-cell lymphoma characterized by a proliferation of arborizing vessels and hyperplastic follicular dendritic cells as well as a polymorphous lymphoid infiltrate including neoplastic cells with clear cytoplasm. Adult T-cell leukemia/lymphoma (ATLL) is caused by the retrovirus human T-cell leukemia virus type I (HTLV-I), and the neoplastic cells are usually large and pleomorphic. Recently, a rare morphologic variant of ATLL with AITL-like features has been reported. Here, we presented a case of peripheral T-cell lymphoma with morphological features of AITL in Taiwan, a country non-endemic for HTLV, and the patient was seropositive for anti-HTLV antibody, which raised the possibility of ATLL with AITL-like features. Immunohistochemically, there were hyperplastic follicular dendritic meshworks by CD21 immunostaining, and the neoplastic cells expressed CD10, programmed death-1, and CXCL13. Furthermore, Southern blot analysis using DNA extracted from the nodal tissue was negative for HTLV-I proviral integration. Our investigations indicated that in an HTLV-I non-endemic area, a peripheral T-cell lymphoma with typical morphologic and immunophenotypic features of AITL could be confidently diagnosed as AITL even if the patient was seropositive for anti-HTLV antibody.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20198459     DOI: 10.1007/s12185-010-0540-x

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  18 in total

Review 1.  Angioimmunoblastic T-cell lymphoma.

Authors:  Ahmet Dogan; Ayoma D Attygalle; Chara Kyriakou
Journal:  Br J Haematol       Date:  2003-06       Impact factor: 6.998

2.  Clonal HTLV-I-infected CD4+ T-lymphocytes and non-clonal non-HTLV-I-infected giant cells in incipient ATLL with Hodgkin-like histologic features.

Authors:  K Ohshima; J Suzumiya; A Kato; K Tashiro; M Kikuchi
Journal:  Int J Cancer       Date:  1997-08-07       Impact factor: 7.396

Review 3.  Current views in HTLV-I-associated adult T-cell leukemia/lymphoma.

Authors:  Christophe Nicot
Journal:  Am J Hematol       Date:  2005-03       Impact factor: 10.047

4.  Expression of CXCL13 by neoplastic cells in angioimmunoblastic T-cell lymphoma (AITL): a new diagnostic marker providing evidence that AITL derives from follicular helper T cells.

Authors:  Jehan Dupuis; Karine Boye; Nadine Martin; Christiane Copie-Bergman; Anne Plonquet; Bettina Fabiani; Anne-Catherine Baglin; Corinne Haioun; Marie-Hélène Delfau-Larue; Philippe Gaulard
Journal:  Am J Surg Pathol       Date:  2006-04       Impact factor: 6.394

5.  Human T-cell lymphotropic virus type I associated adult T-cell leukaemia/lymphoma in Taiwan Chinese.

Authors:  L Y Shih; T T Kuo; P Dunn; S J Liaw
Journal:  Br J Haematol       Date:  1991-10       Impact factor: 6.998

6.  Seroindeterminate HTLV-1 prevalence and characteristics in blood donors in Taiwan.

Authors:  Shih Chien Lu; Bai Hsiun Chen
Journal:  Int J Hematol       Date:  2003-05       Impact factor: 2.490

7.  Programmed death 1 is a marker of angioimmunoblastic T-cell lymphoma and B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia.

Authors:  Luc Xerri; Bruno Chetaille; Nacer Serriari; Nacer Seriari; Coralie Attias; Yves Guillaume; Christine Arnoulet; Daniel Olive
Journal:  Hum Pathol       Date:  2008-05-13       Impact factor: 3.466

8.  Classification of distinct subtypes of peripheral T-cell lymphoma unspecified, identified by chemokine and chemokine receptor expression: Analysis of prognosis.

Authors:  Koichi Ohshima; Kennosuke Karube; Riko Kawano; Takeshi Tsuchiya; Hiroaki Suefuji; Takahiro Yamaguchi; Junji Suzumiya; Masahiro Kikuchii
Journal:  Int J Oncol       Date:  2004-09       Impact factor: 5.650

9.  CD30 (Ki-1) expression in adult T-cell leukaemia/lymphoma is associated with distinctive immunohistological and clinical characteristics.

Authors:  M Takeshita; M Akamatsu; K Ohshima; S Kobari; M Kikuchi; J Suzumiya; N Uike; T Okamura
Journal:  Histopathology       Date:  1995-06       Impact factor: 5.087

10.  Th1, Th2, and activated T-cell marker and clinical prognosis in peripheral T-cell lymphoma, unspecified: comparison with AILD, ALCL, lymphoblastic lymphoma, and ATLL.

Authors:  Takeshi Tsuchiya; Koichi Ohshima; Kennosuke Karube; Takahiro Yamaguchi; Hiroaki Suefuji; Makoto Hamasaki; Chika Kawasaki; Junji Suzumiya; Masao Tomonaga; Masahiro Kikuchi
Journal:  Blood       Date:  2003-09-04       Impact factor: 22.113

View more
  2 in total

Review 1.  Development of peripheral T-cell lymphoma not otherwise specified in an HTLV-1 carrier.

Authors:  Tomohiro Ishigaki; Masamichi Isobe; Seiichiro Kobayashi; Koichiro Yuji; Nobuhiro Ohno; Nobukazu Watanabe; Arinobu Tojo; Kaoru Uchimaru
Journal:  Int J Hematol       Date:  2013-04-09       Impact factor: 2.490

2.  Sequential Complications of Hypercalcemia, Necrotizing Granulomatous Vasculitis, and Aplastic Anemia Occurring in One Patient with Angioimmunoblastic T-cell Lymphoma.

Authors:  Sriman Swarup; Jonathan Kopel; Kyaw Zin Thein; Kaiser Tarafdar; Khatrina Swarup; Seshadri Thirumala; Donald P Quick
Journal:  Am J Med Sci       Date:  2020-09-03       Impact factor: 3.462

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.